Advancing breast reconstruction.
Empowering women.

Women deserve better.

300,000

women in the U.S. are
diagnosed with breast cancer each year₁

130,00

of women choose breast reconstruction after mastectomy each year ₂

1 in 4

breast reconstructions experience complications ₃

1 in 10

breast reconstruction surgeries require re-operation or experience complications due to infection ₃

Our mission is to transform the field of reconstructive surgery for women and their surgeons.

The melodi matrix™

A development stage soft tissue device that elutes antibiotics and absorbs into the body quickly, the Melodi Matrix features a clinically proven technology.

  • Antibacterial

    Antibiotics designed to be released directly into the tissue

  • Absorbable

    Synthetic scaffold is designed to fully dissolve

  • Porous

    Macroporous structure permits tissue ingrowth

  • Expandable

    Pliable to allow for tissue expansion

The first of its kind

A clinical trial is currently being conducted to study the Melodi Matrix in women undergoing breast reconstruction after their mastectomy. Contact us if you’re interested in learning more.

Want to know more?

We’d love to share more about our vision for Melodi Matrix. Send us a message here or email info@melodihealth.com

1. American Cancer Society. Key statistics for breast cancer. cancer.org/cancer/types/breast-cancer/about/how-common-is-breast-cancer.html. January 12, 2023. Accessed June 22, 2023.

2. American Society of Plastic Surgeons. 2019 Plastic Surgery Statistics. plasticsurgery.org/news/plastic-surgery-statistics Accessed June 22, 2023.

3. Sorkin M, Qi J, Kim HM, Hamill JB, Kozlow H, Pusic AL, Wilkins EG. (2017) Acellular Dermal Matrix in Immediate Expander/Implant Breast Reconstruction: A Multicenter Assessment of Risks and Benefits. Plast Reconstr Surg. Dec;140(6):1091-1100.